Literature DB >> 27489109

Chaperonin-containing T-complex Protein 1 Subunit ζ Serves as an Autoantigen Recognized by Human Vδ2 γδ T Cells in Autoimmune Diseases.

Hui Chen1, Hongqin You1, Lifang Wang1, Xuan Zhang2, Jianmin Zhang3, Wei He4.   

Abstract

Human γδ T cells recognize conserved endogenous and stress-induced antigens typically associated with autoimmune diseases. However, the role of γδ T cells in autoimmune diseases is not clear. Few autoimmune disease-related antigens recognized by T cell receptor (TCR) γδ have been defined. In this study, we compared Vδ2 TCR complementarity-determining region 3 (CDR3) between systemic lupus erythematosus (SLE) patients and healthy donors. Results show that CDR3 length distribution differed significantly and displayed oligoclonal characteristics in SLE patients when compared with healthy donors. We found no difference in the frequency of Jδ gene fragment usage between these two groups. According to the dominant CDR3δ sequences in SLE patients, synthesized SL2 peptides specifically bound to human renal proximal tubular epithelial cell line HK-2; SL2-Vm, a mutant V sequence of SL2, did not bind. We identified the putative protein ligand chaperonin-containing T-complex protein 1 subunit ζ (CCT6A) using SL2 as a probe in HK-2 cell protein extracts by affinity chromatography and liquid chromatography-electrospray ionization-tandem mass spectrometry analysis. We found CCT6A expression on the surface of HK-2 cells. Cytotoxicity of only Vδ2 γδ T cells to HK-2 cells was blocked by anti-CCT6A antibody. Finally, we note that CCT6A concentration was significantly increased in plasma of SLE and rheumatoid arthritis patients. These data suggest that CCT6A is a novel autoantigen recognized by Vδ2 γδ T cells, which deepens our understanding of mechanisms in autoimmune diseases.
© 2016 by The American Society for Biochemistry and Molecular Biology, Inc.

Entities:  

Keywords:  CCT6A; CDR3δ; T cell receptor (TCR); antigen; autoantigen; autoimmune disease; autoimmune diseases; cellular immune response; chaperonin-containing T-complex protein 1 subunit zeta; complementarity-determining region 3 delta; gamma delta T cells; immunology

Mesh:

Substances:

Year:  2016        PMID: 27489109      PMCID: PMC5025685          DOI: 10.1074/jbc.M115.700070

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  31 in total

1.  Gamma delta T cells regulate the extent and duration of inflammation in the central nervous system by a Fas ligand-dependent mechanism.

Authors:  Eugene D Ponomarev; Bonnie N Dittel
Journal:  J Immunol       Date:  2005-04-15       Impact factor: 5.422

2.  Qualifying high-throughput immune repertoire sequencing.

Authors:  Norbert Niklas; Johannes Pröll; Johannes Weinberger; Agnes Zopf; Karin Wiesinger; Konstantin Krismer; Peter Bettelheim; Christian Gabriel
Journal:  Cell Immunol       Date:  2014-02-23       Impact factor: 4.868

3.  Tumor recognition following Vgamma9Vdelta2 T cell receptor interactions with a surface F1-ATPase-related structure and apolipoprotein A-I.

Authors:  Emmanuel Scotet; Laurent O Martinez; Ethan Grant; Ronald Barbaras; Paul Jenö; Martine Guiraud; Bernard Monsarrat; Xavier Saulquin; Sophie Maillet; Jean-Pierre Estève; Frédéric Lopez; Bertrand Perret; Xavier Collet; Marc Bonneville; Eric Champagne
Journal:  Immunity       Date:  2005-01       Impact factor: 31.745

4.  CDR3δ -grafted γ9δ2T cells mediate effective antitumor reactivity.

Authors:  Hui Zhao; Xueyan Xi; Lianxian Cui; Wei He
Journal:  Cell Mol Immunol       Date:  2011-09-12       Impact factor: 11.530

5.  Ectopic expression of human MutS homologue 2 on renal carcinoma cells is induced by oxidative stress with interleukin-18 promotion via p38 mitogen-activated protein kinase (MAPK) and c-Jun N-terminal kinase (JNK) signaling pathways.

Authors:  Chen Mo; Yumei Dai; Ning Kang; Lianxian Cui; Wei He
Journal:  J Biol Chem       Date:  2012-04-09       Impact factor: 5.157

6.  Gammadelta T cells recognize tumor cells via CDR3delta region.

Authors:  Chunping Xu; Huiyuan Zhang; Hongbo Hu; Hongbin He; Zhun Wang; Yong Xu; Hui Chen; Wei Cao; Sumei Zhang; Lianxian Cui; Denian Ba; Wei He
Journal:  Mol Immunol       Date:  2006-05-02       Impact factor: 4.407

7.  Targeting solid tumors via T cell receptor complementarity-determining region 3delta in an engineered antibody.

Authors:  Zhun Wang; Tie Zhang; Hongbo Hu; Huiyuan Zhang; Zhi Yang; Lianxian Cui; Wei He
Journal:  Cancer Lett       Date:  2008-09-07       Impact factor: 8.679

8.  The NKG2D ligand ULBP4 binds to TCRgamma9/delta2 and induces cytotoxicity to tumor cells through both TCRgammadelta and NKG2D.

Authors:  Yan Kong; Wei Cao; Xueyan Xi; Chi Ma; Lianxian Cui; Wei He
Journal:  Blood       Date:  2009-05-12       Impact factor: 22.113

9.  Interleukin-1 and IL-23 induce innate IL-17 production from gammadelta T cells, amplifying Th17 responses and autoimmunity.

Authors:  Caroline E Sutton; Stephen J Lalor; Cheryl M Sweeney; Corinna F Brereton; Ed C Lavelle; Kingston H G Mills
Journal:  Immunity       Date:  2009-08-13       Impact factor: 31.745

10.  Identification of human T cell receptor gammadelta-recognized epitopes/proteins via CDR3delta peptide-based immunobiochemical strategy.

Authors:  Hui Chen; Xiaojuan He; Zhun Wang; Di Wu; Huiyuan Zhang; Chunping Xu; Hongbin He; Lianxian Cui; Denian Ba; Wei He
Journal:  J Biol Chem       Date:  2008-03-05       Impact factor: 5.157

View more
  3 in total

1.  Profiling the pattern of the human T-cell receptor γδ complementary determinant region 3 repertoire in patients with lung carcinoma via high-throughput sequencing analysis.

Authors:  Hui Chen; Mingjin Zou; Da Teng; Yu Hu; Jianmin Zhang; Wei He
Journal:  Cell Mol Immunol       Date:  2018-02-05       Impact factor: 11.530

2.  Human regulatory γδT cells and their functional plasticity in the tumor microenvironment.

Authors:  Hui Chen; Wei He
Journal:  Cell Mol Immunol       Date:  2017-08-28       Impact factor: 11.530

Review 3.  T cells and autoimmune kidney disease.

Authors:  Abel Suárez-Fueyo; Sean J Bradley; David Klatzmann; George C Tsokos
Journal:  Nat Rev Nephrol       Date:  2017-03-13       Impact factor: 28.314

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.